Mehmet Burak Ateş

9PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Haematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Evaluation of Serum Prolidase as a Biomarker and the Effects of Nintedanib in an Experimental Rat Model of Silicosis.

|Jul 28, 2026
Early Dose-Related Cardiorenal Effects of Cisplatin: Integrated Biochemical, Molecular and Histopathological Evaluation in an Experimental Rat Model.

|Jun 08, 2026
Detection of Pasteurella multocida and macrolide resistance genes in calf pneumonia: an immunohistochemical and molecular approach.

|Nov 22, 2025
Cisplatin-induced toxicity in the hippocampus: a dose-dependent mechanism of damage.

Melek Altunkaya, Mehmet Burak Ateş, Ayşegül Bulut

|Oct 01, 2025
Innovative design and comprehensive characterization of a valine-enhanced lipid nanoparticle-coated mRNA vaccine targeting the SARS-CoV-2 S-RBD antigen.

Tugce Duran, Naci Cine, Mehmet Ali Karaselek

|Jul 12, 2024
Potential effects of Resatorvid and alpha lipoic acid on gentamicin-induced nephrotoxicity in rats.

Burak Dik, Durmus Hatipoglu, Mehmet Burak Ates

Pageof 2

Frequent Collaborators

3 joint publications

Fatih Hatipoglu

2 joint publications

Mustafa Ortatatli

2 joint publications

Bahadır Öztürk

2 joint publications

Ozgur Ozdemir